Literature DB >> 3990053

Hemostatic defects in experimental obstructive jaundice.

J Kambayashi, T Ohshiro, T Mori, G Kosaki.   

Abstract

To elucidate the etiology of hemostatic abnormalities in cases of obstructive jaundice, we occluded the bile duct of rats for one week and found that the moderately jaundiced rats exhibited a marked reduction in the value of Hepaplastin test and Thrombotest with minimum histological changes in liver. All other coagulation and fibrinolysis profiles were within normal limits. These findings exclude the occurrence of a hypercoagulable state or hypofibrinolytic state in the jaundiced rats due to bile duct occlusion. Similar results were obtained in rats with tube choledochostomy. The abnormalities were almost completely prevented by the daily parenteral administration of vitamin K. These observations suggest that malabsorption of vitamin K may be the sole etiologic factor producing hemostatic defects in case of uncomplicated obstructive jaundice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3990053     DOI: 10.1007/bf02469862

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  5 in total

1.  Renal function and other factors in obstructive jaundice.

Authors:  M E Allison; C R Prentice; A C Kennedy; L H Blumgart
Journal:  Br J Surg       Date:  1979-06       Impact factor: 6.939

Review 2.  The hemostatic defect of liver disease.

Authors:  W D Walls; M S Losowsky
Journal:  Gastroenterology       Date:  1971-01       Impact factor: 22.682

3.  [Clinical and laboratory studies on the development of bleeding tendency in obstructive jaundice (author's transl)].

Authors:  S Takeda
Journal:  Fukuoka Igaku Zasshi       Date:  1977-01

4.  Vitamin K dependent modifications of glutamic acid residues in prothrombin.

Authors:  J Stenflo; P Fernlund; W Egan; P Roepstorff
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

5.  PROTHROMBIN DEFICIENCY THE CAUSE OF BLEEDING IN BILE FISTULA DOGS.

Authors:  W B Hawkins; K M Brinkhous
Journal:  J Exp Med       Date:  1936-05-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.